No Picture
News

Puradigm, LLC announces successful tests of its proactive air and surface purification technology in deactivating SARS-CoV-2, the virus that causes COVID-19, as well as deactivating coronavirus 229E

Results from a study done by the University of Florida using the SARS-CoV-2 virus show a significant decrease in infectivity of the virus immediately after exposure to Puradigm’s technology and show the virus was undetectable after 24 hours of expos… […]

No Picture
News

Microbiologics expands virology capabilities for SARS-CoV-2 with new BSL-3 laboratory at its San Diego facility

SAN DIEGO, Aug. 3, 2020 /PRNewswire/ — Microbiologics announced today that it has recently completed renovations of the virology services laboratory in its San Diego location. With completion of the renovation, Microbiologics has expanded its custo… […]

No Picture
News

Mesa Biotech to Receive up to $15.4 Million Funding from the National Institutes of Health for Accelerated Scale-up and Deployment

Mesa Biotech Among the First Selected for NIH’s Rapid Acceleration of Diagnostics Initiative

SAN DIEGO, July 31, 2020 /PRNewswire/ — Mesa Biotech, developers of an affordable, easy to use, handheld testing platform for infectious diseases dia… […]

No Picture
News

Mesa Biotech to Receive up to $15.4 Million Funding from the National Institutes of Health for Accelerated Scale-up and Deployment

Mesa Biotech Among the First Selected for NIH’s Rapid Acceleration of Diagnostics Initiative

SAN DIEGO, July 31, 2020 /PRNewswire/ — Mesa Biotech, developers of an affordable, easy to use, handheld testing platform for infectious diseases dia… […]

No Picture
News

Helix Selected by the NIH to Become One of the Nation’s COVID-19 “Mega-Labs” and Scale Daily Capacity to 100,000 Tests

Funding from the NIH RADx-ATP program will be used to support rapid scaling of Helix’s end-to-end COVID-19 test system, making it one of the highest throughput COVID-19 laboratories in the country

SAN MATEO, Calif., July 31, 2020 /PRNewswire/ — Heli… […]

No Picture
News

Sorrento Announces License From Columbia University For Rapid On-Site Detection Test For SARS-CoV-2 Virus In Saliva

— Test gives simple positive or negative color change results in 30 minutes or less– No special laboratory equipment required, hence practical for on-site deployment– Test uses saliva, eliminating need for painful nasal swabbing– Study shows sensit… […]

No Picture
News

Exonbio launches high affinity SARS-CoV-2 rabbit monoclonal antibodies to accelerate the global IVD and research community efforts

SAN DIEGO, July 23, 2020 /PRNewswire/ — Exonbio, a leading recombinant antibody CRO company now launches the SARS-CoV-2 Nucleocapsid recombinant monoclonal antibodies for the global IVD and research communities in support of efforts to combat the p… […]

No Picture
News

Qualigen Therapeutics Engages NFL Hall of Famer Mike Haynes as Advisor to the Company and Spokesman for the FastPack® Rapid Diagnostic System “Which Saved My Life”

CARLSBAD, Calif., July 7, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“Qualigen” or the “Company”) announces it has engaged Pro Football Hall of Fame and College Football Hall of Fame inductee Mike Haynes as an advisor to the Co… […]

No Picture
News

Phanes Therapeutics reveals a new bispecific antibody technology platform at BIO Digital 2020

SAN DIEGO, June 16, 2020 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research in immuno-oncology announced today that it has developed a proprietary bispecific antibody technology platform, PACbodyT… […]

No Picture
News

Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement with Humanigen for Lenzilumab, Currently in FDA-Approved Phase III Study for COVID-19

SAN DIEGO, May 27, 2020 /PRNewswire/ — Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce it has entered into a manufacturing agreement w… […]

No Picture
News

Maintaining a Healthy Upper Respiratory Tract Microbiome May Help Prevent Secondary Infections in Influenza A Patients

An influenza-impacted upper respiratory tract microbiome may invite opportunistic bacterial pathogens

LA JOLLA, Calif., May 26, 2020 /PRNewswire/ — Scientists from the J. Craig Venter Institute (JCVI), Icahn School of Medicine at Mount Sinai, and Po… […]

No Picture
News

Roswell Biotechnologies and Imec to Develop First Molecular Electronics Biosensor Chips for Infectious Disease Surveillance, Precision Medicine and DNA Storage

Technology Advances Rapid, Cost-effective DNA Sequencing on Portable Devices

SAN DIEGO and LEUVEN, Belgium, May 5, 2020 /PRNewswire/ — Roswell Biotechnologies, Inc., the leader in molecular electronics sensor chips, and imec, a world-leading researc… […]

No Picture
News

Roswell Biotechnologies and Imec to Develop First Molecular Electronics Biosensor Chips for Infectious Disease Surveillance, Precision Medicine and DNA Storage

Technology Advances Rapid, Cost-effective DNA Sequencing on Portable Devices

SAN DIEGO and LEUVEN, Belgium, May 5, 2020 /PRNewswire/ — Roswell Biotechnologies, Inc., the leader in molecular electronics sensor chips, and imec, a world-leading researc… […]

No Picture
News

Sweetwater Private Equity recognizes Adaptive Biotechnologies Corp. and its CEO Chad Robins for leadership during COVID-19 crisis

SAN DIEGO, April 28, 2020 /PRNewswire/ –?Sweetwater Investment Management (“Sweetwater” or “Sweetwater Private Equity” (dba)) announced during their recent annual investor meeting the selection of Chad Robins, CEO of Adaptive Biotechnologies Corp. … […]

No Picture
News

Ansun Biopharma Enrolls First Patient in Proof of Concept Trial of DAS181 for the Treatment of COVID-19

New study will build on recent clinical evidence showing efficacy of DAS181 in improving symptoms of patients with severe COVID-19Clinical study initiated at 12 US sites, including leading academic medical centers

SAN DIEGO, April 15, 2020 /PRNewswir… […]

No Picture
News

Active Motif launches a portfolio of recombinant COVID-19 antibodies; the first full human antibodies derived from patients infected with the 2019 Coronavirus, now available for research and commercial use

CARLSBAD, Calif., April 9, 2020 /PRNewswire/ –?On February 26, 2020, Active Motif announced the successful isolation of antibodies from patients in China recovering from 2019 Coronavirus related pneumonia (COVID-19). The full suite of antibodies is… […]

No Picture
News

Mesa Biotech To Ship 10,000 Accula SARS-CoV-2 Tests This Week For 30 Minute Rapid Molecular Point of Care Diagnosis

The only FDA authorized palm-sized system for COVID-19 testing enables broader use across healthcare facilities and closer to the patients with rapid results

SAN DIEGO, April 7, 2020 /PRNewswire/ –?Today, Mesa Biotech announced it is shipping 10,000… […]

No Picture
News

Viscient Biosciences Will Bioprint 3D Lung Tissue to Aid Pandemic Research, and Viscient Founder Calls for Pause in Organovo Merger Attempt

Viscient will turn its attention to 3D bioprinting lung tissue for infectivity research to assist global efforts to combat SARS-CoV-2, the novel coronavirus that causes COVID-19Organovo failed to receive a majority of stockholder votes in favor of its … […]